San Diego, CA, United States of America

David Cerny


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Cerny: Innovator in Rare Cell Detection

Introduction

David Cerny is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of biological sample analysis, particularly in the detection and isolation of rare cells. His innovative work has the potential to impact cancer research and diagnostics.

Latest Patents

David Cerny holds a patent for "Methods and compositions for detecting rare cells from a biological sample." This patent outlines methods and compositions for isolating and detecting rare cells from biological samples that contain various other cell types. The invention includes a microfabricated filter for filtering samples, which allows for the enrichment of rare cells. These enriched cells can be utilized in downstream processes such as identification, characterization, or growth in culture. Additionally, the patent describes a method for determining tumor aggressiveness or the proportion of cancer cells in the enriched sample by detecting telomerase activity or nucleic acid expression. The invention also provides an efficient method to specifically remove red and white blood cells from a biological sample, leading to the enrichment of rare target cells, including circulating tumor cells and other non-hematopoietic cells.

Career Highlights

David Cerny is currently associated with Aviva Biosciences Corporation, where he continues to advance his research and innovations. His work is crucial in the development of technologies that enhance the detection of rare cells, which can play a vital role in medical diagnostics and treatment strategies.

Collaborations

David collaborates with notable colleagues, including Ping Lin and Andrea Ghetti. Their combined expertise contributes to the advancement of research in the field of rare cell detection.

Conclusion

David Cerny is a key figure in the innovation of methods for detecting rare cells, with a patent that showcases his contributions to medical science. His work at Aviva Biosciences Corporation and collaborations with other experts highlight the importance of his research in improving cancer diagnostics and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…